Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.9B | 6.3B | 5.8B | 6.0B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 423M | 412M | 424M | 420M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 3.5B | 4.0B | 3.8B | 3.5B |
| Tax provision | 690M | 796M | 741M | 695M |
| Net income | 2.8B | 3.2B | 3.1B | 2.8B |
| Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Basic average shares | 3.2B | 3.2B | 3.2B | 3.2B |
| Diluted average shares | 3.2B | 3.2B | 3.2B | 3.2B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 2.8B | 3.2B | 3.2B | 2.8B |